Breaking News

You are here » Indian-Commodity  :  Commodities  :  Jeera  :  Jeera futures decline on favourable climate conditions

21-Sep2018

Jeera futures decline on favourable climate conditions

Jeera futures declined on NCDEX, due to liquidation of bets at prevailing high price levels counting on improved rains in the central Gujarat major Jeera producing area. However, improved physical and export demand failed to provide any momentum.

The contract for October delivery was trading at Rs 19420.00, down by 0.92% or Rs 180.00 from its previous closing of Rs 19600.00. The open interest of the contract stood at 7413 lots.

The contract for November delivery was trading at Rs 19630.00, down by 0.96% or Rs 190.00 from its previous closing of Rs 19820.00. The open interest of the contract stood at 1278 lots on NCDEX.


Related News

View all news

Jeera futures trade lower on NCDEX

Jeera futures traded lower on NCDEX, as speculators reduced exposure on account of reduced export demand in the physical market. Moreover, expectation of higher production due to adequate availability......

Jeera futures trade lower on NCDEX

Jeera futures traded lower on NCDEX, as speculators reduced exposure on account of reduced export demand in the physical market. Moreover, expectation of higher production due to adequate availability......

Jeera futures trade higher on NCDEX

Jeera futures traded higher on NCDEX, on account of decline in crop in Gujarat due to lower acreage However, lower export demand in the physical market, trimmed some gains.The contract for March delivery......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......